Dow Up 0.93% Nasdaq Up 1.18%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.62 Down 0.01(0.19%) 12:43PM EDT - Nasdaq Real Time Price
Prev Close:2.62
Open:2.69
Bid:2.60 x 2400
Ask:2.61 x 400
1y Target Est:7.00
Beta:3.36
Next Earnings Date: 6-Nov-14IDRA Earnings announcement
Day's Range:2.60 - 2.72
52wk Range:1.55 - 6.87
Volume:210,700
Avg Vol (3m):780,462
Market Cap:219.05M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IDRA

Comparison

Symbol% ChgMkt Cap
IDRADown 0.19%219.05M
DVAXDown 1.18%439.01M
PFEUp 0.62%190.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,220.57
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback